Abstract:Pulmonary oedema in two parturients with hypertrophic obstructive cardiomyopathy (HOES)TwoHypertrophic obstructive cardiomyopathy (HOES) is a relatively recently described abnormality which appears to be increasing in frequency.' It is observed in all races, at all ages, in both sexes and can be lethal, z-4Hypertrophic obstructive cardiomyopathy presents a major challenge to the anaesthetist managing parturients. Women in labour are stressed by the pain of labour and its associated increase in catecholamine se… Show more
“…As noted previously, tachycardia shortens the left ventricular diastolic filling period, decreasing preload, and exacerbates outflow obstruction. Moreover, performance of the Valsalva maneuver during labor and delivery, which helps the fetus descend during the second stage of labor, can also impair venous return and impairs cardiac output in patients with significant obstruction (68). A similar problem can occur in the setting of substantial blood loss during or after delivery (69).…”
Section: Hypertrophic Cardiomyopathymentioning
confidence: 97%
“…Most women received general anesthesia out of concern for a rapid fall in systemic vascular resistance in patients with a fixed cardiac output due to the degree of outflow stenosis. Vasopressor agents and fluids can be given to treat hypotension, but it is preferable to use a pure alpha-agonist such as phenylephrine, because it lacks any inotropic properties (68). In HCM, inotropes can worsen the outflow gradient and are relatively contraindicated (51).…”
To varying extents, women with pre-existing cardiomyopathies have a limited cardiovascular reserve. The hemodynamic challenges of pregnancy, labor, and delivery pose unique risks to this group of patients, which can result in clinical decompensation with overt heart failure, arrhythmias, and rarely, maternal death. A multidisciplinary team approach and a controlled delivery are crucial to adequate management of patients with underlying heart disease. Pre-conception planning and risk assessment are essential, and proper counseling should be offered to expectant mothers with regard to both the risks that pregnancy poses and the implications for future offspring. In this article, we will review the hemodynamic stressors that pregnancy places upon women with pre-existing cardiomyopathies and risk assessment and discuss what evidence exists with regard to the management of 2 forms of cardiomyopathy during pregnancy, labor, and delivery: dilated and hypertrophic cardiomyopathy.
“…As noted previously, tachycardia shortens the left ventricular diastolic filling period, decreasing preload, and exacerbates outflow obstruction. Moreover, performance of the Valsalva maneuver during labor and delivery, which helps the fetus descend during the second stage of labor, can also impair venous return and impairs cardiac output in patients with significant obstruction (68). A similar problem can occur in the setting of substantial blood loss during or after delivery (69).…”
Section: Hypertrophic Cardiomyopathymentioning
confidence: 97%
“…Most women received general anesthesia out of concern for a rapid fall in systemic vascular resistance in patients with a fixed cardiac output due to the degree of outflow stenosis. Vasopressor agents and fluids can be given to treat hypotension, but it is preferable to use a pure alpha-agonist such as phenylephrine, because it lacks any inotropic properties (68). In HCM, inotropes can worsen the outflow gradient and are relatively contraindicated (51).…”
To varying extents, women with pre-existing cardiomyopathies have a limited cardiovascular reserve. The hemodynamic challenges of pregnancy, labor, and delivery pose unique risks to this group of patients, which can result in clinical decompensation with overt heart failure, arrhythmias, and rarely, maternal death. A multidisciplinary team approach and a controlled delivery are crucial to adequate management of patients with underlying heart disease. Pre-conception planning and risk assessment are essential, and proper counseling should be offered to expectant mothers with regard to both the risks that pregnancy poses and the implications for future offspring. In this article, we will review the hemodynamic stressors that pregnancy places upon women with pre-existing cardiomyopathies and risk assessment and discuss what evidence exists with regard to the management of 2 forms of cardiomyopathy during pregnancy, labor, and delivery: dilated and hypertrophic cardiomyopathy.
“…6 This suggests that hypovolaemia during pregnancy is of greater concern than hypervolaemia. Due to the low incidence of adverse events, especially pulmonary oedema, 7 it has not been possible to correlate symptom severity or echocardiographic findings with outcome. Absolute mortality is low, at 10 per 1000 live births, but is greater than in the non-pregnant HCM population.…”
Section: Discussionmentioning
confidence: 98%
“…Cautious fluid administration is required given that pulmonary oedema has been reported post partum in HCM patients. 7 Information from the TTE aided management decisions and was obtained non-invasively. Although the choice of anaesthetic technique for caesarean section should be made on an individual basis, TTE eliminates the need for general anaesthesia for TOE.…”
“…Pulmonary edema has been observed in parturients with HCM after delivery, emphasizing the delicate fluid management in these patients. [10] CONCLUSION Three patients with HCM undergoing different surgical procedures are presented. It may be worth emphasizing that successful anesthetic management of a patient with HCM requires thorough understanding of the hemodynamic changes, proper intraoperative vigilance, avoiding factors that may increase LVOT obstruction with proper medication and intravascular fluid therapy.…”
Hypertrophic cardiomyopathy with or without left ventricular outflow tract obstruction is characterized by asymmetric hypertrophy of the interventricular septum causing intermittent obstruction of the left ventricular outflow tract. Because Hypertrophic cardiomyopathy is the most common genetic cardiovascular disease, it may present to the anesthesiologist more often than anticipated, sometimes in undiagnosed form during routine preoperative visit. Surgery and anesthesia often complicate the perioperative outcome if adequate monitoring and proper care are not taken. Therefore, a complete understanding of the pathophysiology, hemodynamic changes and anesthetic implications is needed for successful perioperative outcome. We hereby describe the perioperative management of three patients with Hypertrophic cardiomyopathy for different surgical procedures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.